Contezolid for the Treatment of Drug-Resistant Tuberculosis in China: A Clinical Case Series
Introduction The 2023 World Health Organization (WHO) report indicates that tuberculosis (TB) remains a global public health threat.1 Compared with those of drug-sensitive TB, treatment regimens for drug-resistant tuberculosis (DR-TB) are characterized by …